1955
DOI: 10.1136/bmj.1.4917.817
|View full text |Cite
|
Sign up to set email alerts
|

The Treatment of Essential Hypertension with Pentolinium Tartrate Combined with Rauwolfia Alkaloids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1955
1955
1960
1960

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…The daily dose of reserpine administered to these patients was quite small. This is of importance, as the drug is in vogue as a hypotensive agent, being also combined with pentolinium tartrate for the treatment of hypertension (Smirk et al, 1954;Bain et al, 1955;Doyle et al, 1955). Furthermore, Smirk and McQueen (1955) reported that reserpine therapy had to be abandoned in one of their patients on account of fluid retention with recurrence of the manifestations of congestive cardiac failure.…”
Section: Problem Resultsmentioning
confidence: 99%
“…The daily dose of reserpine administered to these patients was quite small. This is of importance, as the drug is in vogue as a hypotensive agent, being also combined with pentolinium tartrate for the treatment of hypertension (Smirk et al, 1954;Bain et al, 1955;Doyle et al, 1955). Furthermore, Smirk and McQueen (1955) reported that reserpine therapy had to be abandoned in one of their patients on account of fluid retention with recurrence of the manifestations of congestive cardiac failure.…”
Section: Problem Resultsmentioning
confidence: 99%
“…This dosage is increased until satisfactory control of the blood pressure is achieved; the final dosage may be from 60 mg. to 500 mg. daily. Smirk et al (33) and Bain et al (34) have described this method. The combination with reserpine allows a smaller dosage of pentolinium to be used, and the blood pressure fluctuates less with this than with the ganglion‐blocking agent alone.…”
Section: Methods Of Treatmentmentioning
confidence: 99%
“…A preference for pentolinium was expressed by two patients (Cases 2 and 5) who have had extensive experience of ganglion-blocking agents. Bain et al (1955) have shown that combination of reserpine with pentolinium enabled reduction in dosage of the latter and thereby a decrease in side-actions. Combined dosage of reserpine and ecolid was used in the maintenance treatment of Cases 7-12, reserpine, 2 mg. by mouth, being ECOLID BRITISH MEDICAL JOURNAL given in the evening.…”
Section: Clinical Investigationmentioning
confidence: 99%